World Cancer Day promotes awareness and patient-centered cancer care, marking the 25th anniversary of the Charter of Paris Against Cancer. The 'United by Unique' campaign highlights the individuality ...

Renuka Iyer, M.D., will assume the role of CMO at NCCN, focusing on advancing evidence-based cancer care and guideline ...

The National Comprehensive Cancer Network Oncology Research Program announces funding for research projects to advance treatment for people with stage four breast cancer.

The National Comprehensive Cancer Network Oncology Research Program awards funding to researchers from Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic ...

Free information from the National Comprehensive Cancer Network offers information on how and why to access genetic counseling and testing for multiple hereditary cancers “No other landscape in ...

The National Comprehensive Cancer Network (NCCN) survey finds 89% of centers continue to report shortages for at least one type of systemic therapy. In a recent survey conducted by the National ...

PLYMOUTH MEETING, PA [October 6, 2025] — Today, the National Comprehensive Cancer Network ® (NCCN ®)—a nonprofit responsible for globally utilized guidelines for cancer care—is sharing new NCCN ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Experts at the National Comprehensive Cancer Network (NCCN) have now issued an updated ...

Initial pilot study data validate feasibility and applicability of HERC in advancing equitable cancer care delivery at leading cancer centers. MINNEAPOLIS, Oct. 28, 2024 /PRNewswire/ -- Today, the ...

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today commented on recent updates by the NCCN on circulating tumor DNA (ctDNA) ...

The National Comprehensive Cancer Network ® (NCCN ®) - an alliance of leading cancer centers - and the NCCN Foundation ® proudly announce plans to make every book in the library of NCCN Guidelines for ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic Classifier is the ...